by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Alcoholism
A new study published in the Journal of Psychopharmacology is reporting on a landmark clinical trial exploring the potential for MDMA-assisted psychotherapy in treating subjects with alcohol use disorder. The small open-label trial is the first to test MDMA therapy as...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Anxiety, Depression, Microdosing
A first of its kind “self-blinded” trial testing the effect of psychedelic microdosing has found the anecdotally popular practice may be an example of a strong placebo effect. The research, led by Imperial College London, suggests there is little...
by EmpathiCSubstanceS | Apr 25, 2021 | Addiction, Anxiety, Depression
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
by EmpathiCSubstanceS | Nov 10, 2020 | Addiction, Alcoholism, Anxiety
A new study is helping clarify what is going on in our brains when we hallucinate. To do this, researchers from the University of Oregon dosed mice with a powerful psychedelic drug and with unprecedented detail zoomed in on how the animal’s brains subsequently...
by EmpathiCSubstanceS | Nov 10, 2020 | Pain
In a first-of-its-kind study, a team of researchers from the University of California, Davis has examined the effects of psychedelic microdosing on animal behavior. The results yielded a variety of unexpected effects including some surprising negative changes...
